{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:03:09Z","timestamp":1773270189935,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012834","name":"Gifu University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00520-026-10487-3","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:52:55Z","timestamp":1772610775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dose-dependent association of naldemedine and magnesium oxide in the management of opioid-induced constipation"],"prefix":"10.1007","volume":"34","author":[{"given":"Ryo","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakika","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"10487_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5055\/jom.2009.0014","volume":"5","author":"T Bell","year":"2009","unstructured":"Bell T, Annunziata K, Leslie JB (2009) Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag 5:137\u2013144. https:\/\/doi.org\/10.5055\/jom.2009.0014","journal-title":"J Opioid Manag"},{"key":"10487_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0686-6","author":"R Mes\u00eda","year":"2019","unstructured":"Mes\u00eda R, Virizuela Echaburu JA, G\u00f3mez J et al (2019) Opioid-induced constipation in oncological patients: new strategies of management. Curr Treat Options Oncol. https:\/\/doi.org\/10.1007\/s11864-019-0686-6","journal-title":"Curr Treat Options Oncol"},{"key":"10487_CR3","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1002\/cam4.2341","volume":"8","author":"A Tokoro","year":"2019","unstructured":"Tokoro A, Imai H, Fumita S et al (2019) Incidence of opioid-induced constipation in Japanese patients with cancer pain: a prospective observational cohort study. Cancer Med 8:4883\u20134891. https:\/\/doi.org\/10.1002\/cam4.2341","journal-title":"Cancer Med"},{"key":"10487_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jjco\/hyae135","volume":"55","author":"T Kessoku","year":"2025","unstructured":"Kessoku T, Akamatsu T, Morioka Y et al (2025) Effect of add-on naldemedine treatment in patients with cancer and opioid-induced constipation insufficiently responding to magnesium oxide: a pooled, subgroup analysis of two randomized controlled trials. Jpn J Clin Oncol 55:40\u201348. https:\/\/doi.org\/10.1093\/jjco\/hyae135","journal-title":"Jpn J Clin Oncol"},{"key":"10487_CR5","doi-asserted-by":"publisher","unstructured":"Takemura M, et al (2022) Naldemedine-laxative combination: retrospective inpatient study. BMJ Support Palliat Care. https:\/\/https:\/\/doi.org\/10.1136\/bmjspcare-2022-003685. PMID: 35750467","DOI":"10.1136\/bmjspcare-2022-003685"},{"key":"10487_CR6","doi-asserted-by":"publisher","unstructured":"Yamada M, et al (2023) A Retrospective observational study of factors affecting the preventive effectiveness of naldemedine for opioid-induced constipation. Biol Pharm Bull. https:\/\/https:\/\/doi.org\/10.1248\/bpb.b23-00487. PMID: 38044102","DOI":"10.1248\/bpb.b23-00487"},{"key":"10487_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40122-023-00520-2","volume":"12","author":"T Higashibata","year":"2023","unstructured":"Higashibata T, Kessoku T, Morioka Y et al (2023) A nationwide hospital claims database analysis of real-world patterns of laxative use for opioid-induced constipation in Japanese patients with cancer. Pain Ther 12:993\u20131003. https:\/\/doi.org\/10.1007\/s40122-023-00520-2","journal-title":"Pain Ther"},{"key":"10487_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13020421","volume":"13","author":"H Mori","year":"2021","unstructured":"Mori H, Tack J, Suzuki H (2021) Magnesium oxide in constipation. Nutrients 13:1\u201312","journal-title":"Nutrients"},{"key":"10487_CR9","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/jpm.2021.0438","volume":"25","author":"H Mawatari","year":"2022","unstructured":"Mawatari H, Shinjo T, Morita T et al (2022) Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese Society of Palliative Medicine. J Palliat Med 25:1095\u20131114. https:\/\/doi.org\/10.1089\/jpm.2021.0438","journal-title":"J Palliat Med"},{"key":"10487_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00520-009-0775-3","volume":"18","author":"M Ishihara","year":"2010","unstructured":"Ishihara M, Iihara H, Okayasu S et al (2010) Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients. Support Care Cancer 18:1531\u20131538. https:\/\/doi.org\/10.1007\/s00520-009-0775-3","journal-title":"Support Care Cancer"},{"key":"10487_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2169\/internalmedicine.45.1482","volume":"45","author":"S Onishi","year":"2006","unstructured":"Onishi S, Yoshino S (2006) Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 45:207\u2013210. https:\/\/doi.org\/10.2169\/internalmedicine.45.1482","journal-title":"Intern Med"},{"key":"10487_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2011.09.004","author":"YM Weng","year":"2013","unstructured":"Weng YM, Chen SY, Chen HC et al (2013) Hypermagnesemia in a constipated female. J Emerg Med. https:\/\/doi.org\/10.1016\/j.jemermed.2011.09.004","journal-title":"J Emerg Med"},{"key":"10487_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12600","author":"H Ibuka","year":"2016","unstructured":"Ibuka H, Ishihara M, Suzuki A et al (2016) Antacid attenuates the laxative action of magnesia in cancer patients receiving opioid analgesic. J Pharm Pharmacol. https:\/\/doi.org\/10.1111\/jphp.12600","journal-title":"J Pharm Pharmacol"},{"key":"10487_CR14","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/nmo.12417","volume":"26","author":"M Camilleri","year":"2014","unstructured":"Camilleri M, Drossman DA, Becker G et al (2014) Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil 26:1386\u20131395","journal-title":"Neurogastroenterol Motil"},{"key":"10487_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/cpdd.387","volume":"7","author":"K Fukumura","year":"2018","unstructured":"Fukumura K, Yokota T, Baba Y, Arjona Ferreira JC (2018) Phase 1, randomized, double-blind, placebo-controlled studies on the safety, tolerability, and pharmacokinetics of naldemedine in healthy volunteers. Clin Pharmacol Drug Dev 7:474\u2013483. https:\/\/doi.org\/10.1002\/cpdd.387","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10487_CR16","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/pm\/pnw325","volume":"18","author":"LR Webster","year":"2017","unstructured":"Webster LR, Yamada T, Ferreira JCA (2017) A phase 2b, randomized, double-blind placebo-controlled study to evaluate the efficacy and safety of naldemedine for the treatment of opioid-induced constipation in patients with chronic noncancer pain. Pain Med 18:2350\u20132360. https:\/\/doi.org\/10.1093\/pm\/pnw325","journal-title":"Pain Med"},{"key":"10487_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13563","author":"T Kanemasa","year":"2019","unstructured":"Kanemasa T, Koike K, Arai T et al (2019) Pharmacologic effects of naldemedine, a peripherally acting \u03bc-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation. Neurogastroenterol Motil. https:\/\/doi.org\/10.1111\/nmo.13563","journal-title":"Neurogastroenterol Motil"},{"key":"10487_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1200\/JCO","volume":"35","author":"N Katakami","year":"2017","unstructured":"Katakami N, Oda K, Tauchi K et al (2017) Journal of Clinical Oncology Phase IIb, randomized, double-blind, placebo-controlled study of naldemedine for the treatment of opioid-induced constipation in patients with cancer. J Clin Oncol 35:1921\u20131928. https:\/\/doi.org\/10.1200\/JCO","journal-title":"J Clin Oncol"},{"key":"10487_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ijc.11416","volume":"107","author":"K Mystakidou","year":"2003","unstructured":"Mystakidou K, Tsilika E, Parpa E et al (2003) Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl. Int J Cancer 107:486\u2013492. https:\/\/doi.org\/10.1002\/ijc.11416","journal-title":"Int J Cancer"},{"key":"10487_CR20","doi-asserted-by":"crossref","unstructured":"Radbruch L, Sabatowski R, Loick G, et al (2000) Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine","DOI":"10.1191\/026921600671594561"},{"key":"10487_CR21","doi-asserted-by":"crossref","unstructured":"Van Buuren S, Groothuis-Oudshoorn K (2011) Journal of Statistical Software mice: multivariate imputation by chained equations in R","DOI":"10.18637\/jss.v045.i03"},{"key":"10487_CR22","unstructured":"(2018) WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization"},{"key":"10487_CR23","doi-asserted-by":"crossref","unstructured":"Ishihara M, Ikesue H, Matsunaga H, et al (2012) A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction group for the relief of opioid-induced gastrointestinal dysfunction (J-RIGID)","DOI":"10.1097\/AJP.0b013e318237d626"},{"key":"10487_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ajg.2011.30","volume":"106","author":"M Camilleri","year":"2011","unstructured":"Camilleri M (2011) Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 106:835\u2013842","journal-title":"Am J Gastroenterol"},{"key":"10487_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1756283X15589526","volume":"8","author":"JL Poulsen","year":"2015","unstructured":"Poulsen JL, Brock C, Olesen AE et al (2015) Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therap Adv Gastroenterol 8:360\u2013372","journal-title":"Therap Adv Gastroenterol"},{"key":"10487_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092112","author":"A Ozaki","year":"2022","unstructured":"Ozaki A, Kessoku T, Tanaka K et al (2022) Effectiveness of naldemedine compared with magnesium oxide in preventing opioid-induced constipation: a randomized controlled trial. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14092112","journal-title":"Cancers (Basel)"},{"key":"10487_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00228-014-1694-x","volume":"70","author":"M Yamasaki","year":"2014","unstructured":"Yamasaki M, Funakoshi S, Matsuda S et al (2014) Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy. Eur J Clin Pharmacol 70:921\u2013924. https:\/\/doi.org\/10.1007\/s00228-014-1694-x","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10487-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10487-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10487-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:40Z","timestamp":1773215140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10487-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10487"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10487-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}